264 related articles for article (PubMed ID: 33939491)
1. Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update.
Griggs JJ; Bohlke K; Balaban EP; Dignam JJ; Hall ET; Harvey RD; Hecht DP; Klute KA; Morrison VA; Pini TM; Rosner GL; Runowicz CD; Shayne M; Sparreboom A; Turner S; Zarwan C; Lyman GH
J Clin Oncol; 2021 Jun; 39(18):2037-2048. PubMed ID: 33939491
[TBL] [Abstract][Full Text] [Related]
2. Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline.
Griggs JJ; Mangu PB; Anderson H; Balaban EP; Dignam JJ; Hryniuk WM; Morrison VA; Pini TM; Runowicz CD; Rosner GL; Shayne M; Sparreboom A; Sucheston LE; Lyman GH;
J Clin Oncol; 2012 May; 30(13):1553-61. PubMed ID: 22473167
[TBL] [Abstract][Full Text] [Related]
3. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
4. Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update.
Loprinzi CL; Lacchetti C; Bleeker J; Cavaletti G; Chauhan C; Hertz DL; Kelley MR; Lavino A; Lustberg MB; Paice JA; Schneider BP; Lavoie Smith EM; Smith ML; Smith TJ; Wagner-Johnston N; Hershman DL
J Clin Oncol; 2020 Oct; 38(28):3325-3348. PubMed ID: 32663120
[TBL] [Abstract][Full Text] [Related]
5. How to Manage the Obese Patient With Cancer.
Renehan AG; Harvie M; Cutress RI; Leitzmann M; Pischon T; Howell S; Howell A
J Clin Oncol; 2016 Dec; 34(35):4284-4294. PubMed ID: 27903151
[TBL] [Abstract][Full Text] [Related]
6. Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update.
Bohlius J; Bohlke K; Castelli R; Djulbegovic B; Lustberg MB; Martino M; Mountzios G; Peswani N; Porter L; Tanaka TN; Trifirò G; Yang H; Lazo-Langner A
Blood Adv; 2019 Apr; 3(8):1197-1210. PubMed ID: 30971397
[TBL] [Abstract][Full Text] [Related]
7. Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline.
Braun IM; Bohlke K; Abrams DI; Anderson H; Balneaves LG; Bar-Sela G; Bowles DW; Chai PR; Damani A; Gupta A; Hallmeyer S; Subbiah IM; Twelves C; Wallace MS; Roeland EJ
J Clin Oncol; 2024 May; 42(13):1575-1593. PubMed ID: 38478773
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy dosing in overweight and obese patients with cancer.
Lyman GH; Sparreboom A
Nat Rev Clin Oncol; 2013 Aug; 10(8):451-9. PubMed ID: 23856744
[TBL] [Abstract][Full Text] [Related]
9. Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update.
Hanna NH; Robinson AG; Temin S; Baker S; Brahmer JR; Ellis PM; Gaspar LE; Haddad RY; Hesketh PJ; Jain D; Jaiyesimi I; Johnson DH; Leighl NB; Moffitt PR; Phillips T; Riely GJ; Rosell R; Schiller JH; Schneider BJ; Singh N; Spigel DR; Tashbar J; Masters G
J Clin Oncol; 2021 Mar; 39(9):1040-1091. PubMed ID: 33591844
[TBL] [Abstract][Full Text] [Related]
10. Duration of Oxaliplatin-Containing Adjuvant Therapy for Stage III Colon Cancer: ASCO Clinical Practice Guideline.
Lieu C; Kennedy EB; Bergsland E; Berlin J; George TJ; Gill S; Gold PJ; Hantel A; Jones L; Mahmoud N; Meyerhardt J; Morris AM; Ruíz-García E; You YN; Baxter N
J Clin Oncol; 2019 Jun; 37(16):1436-1447. PubMed ID: 30986117
[TBL] [Abstract][Full Text] [Related]
11. Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH Clinical Practice Guideline Update.
Bohlius J; Bohlke K; Castelli R; Djulbegovic B; Lustberg MB; Martino M; Mountzios G; Peswani N; Porter L; Tanaka TN; Trifirò G; Yang H; Lazo-Langner A
J Clin Oncol; 2019 May; 37(15):1336-1351. PubMed ID: 30969847
[TBL] [Abstract][Full Text] [Related]
12. Dosing considerations for obese patients receiving cancer chemotherapeutic agents.
Hall RG; Jean GW; Sigler M; Shah S
Ann Pharmacother; 2013 Dec; 47(12):1666-74. PubMed ID: 24259627
[TBL] [Abstract][Full Text] [Related]
13. Antineoplastic dosing in overweight and obese cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper.
Silvestris N; Argentiero A; Natalicchio A; D'Oronzo S; Beretta GD; Acquati S; Adinolfi V; Di Bartolo P; Danesi R; Faggiano A; Ferrari P; Gallo M; Gori S; Morviducci L; Russo A; Tuveri E; Zatelli MC; Montagnani M; Giorgino F
ESMO Open; 2021 Jun; 6(3):100153. PubMed ID: 33984679
[TBL] [Abstract][Full Text] [Related]
14. Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update.
Taplitz RA; Kennedy EB; Bow EJ; Crews J; Gleason C; Hawley DK; Langston AA; Nastoupil LJ; Rajotte M; Rolston K; Strasfeld L; Flowers CR
J Clin Oncol; 2018 May; 36(14):1443-1453. PubMed ID: 29461916
[TBL] [Abstract][Full Text] [Related]
15. Use of Opioids for Adults With Pain From Cancer or Cancer Treatment: ASCO Guideline.
Paice JA; Bohlke K; Barton D; Craig DS; El-Jawahri A; Hershman DL; Kong LR; Kurita GP; LeBlanc TW; Mercadante S; Novick KLM; Sedhom R; Seigel C; Stimmel J; Bruera E
J Clin Oncol; 2023 Feb; 41(4):914-930. PubMed ID: 36469839
[TBL] [Abstract][Full Text] [Related]
16. Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update.
Hesketh PJ; Kris MG; Basch E; Bohlke K; Barbour SY; Clark-Snow RA; Danso MA; Dennis K; Dupuis LL; Dusetzina SB; Eng C; Feyer PC; Jordan K; Noonan K; Sparacio D; Somerfield MR; Lyman GH
J Clin Oncol; 2017 Oct; 35(28):3240-3261. PubMed ID: 28759346
[TBL] [Abstract][Full Text] [Related]
17. Effects of tumor type, degree of obesity, and chemotherapy regimen on chemotherapy dose intensity in obese cancer patients.
Miyahara T; Mochinaga S; Kimura S; Aragane N; Yakabe T; Morita S; Okudaira K; Fujito H
Cancer Chemother Pharmacol; 2013 Jan; 71(1):175-82. PubMed ID: 23064956
[TBL] [Abstract][Full Text] [Related]
18. Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update.
Hanna NH; Schneider BJ; Temin S; Baker S; Brahmer J; Ellis PM; Gaspar LE; Haddad RY; Hesketh PJ; Jain D; Jaiyesimi I; Johnson DH; Leighl NB; Phillips T; Riely GJ; Robinson AG; Rosell R; Schiller JH; Singh N; Spigel DR; Stabler JO; Tashbar J; Masters G
J Clin Oncol; 2020 May; 38(14):1608-1632. PubMed ID: 31990617
[TBL] [Abstract][Full Text] [Related]
19. Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused Update.
Denduluri N; Chavez-MacGregor M; Telli ML; Eisen A; Graff SL; Hassett MJ; Holloway JN; Hurria A; King TA; Lyman GH; Partridge AH; Somerfield MR; Trudeau ME; Wolff AC; Giordano SH
J Clin Oncol; 2018 Aug; 36(23):2433-2443. PubMed ID: 29787356
[TBL] [Abstract][Full Text] [Related]
20. Impact of hospital guideline for weight-based antimicrobial dosing in morbidly obese adults and comprehensive literature review.
Polso AK; Lassiter JL; Nagel JL
J Clin Pharm Ther; 2014 Dec; 39(6):584-608. PubMed ID: 25203631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
